This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Nov 15;35(10):1273-5.

doi: 10.1086/343746.

The safety of voriconazole

Brian A Potoski, Jack Brown

PMID: 12410490
DOI: 10.1086/343746

Comment

The safety of voriconazole

Brian A Potoski et al. Clin Infect Dis. 2002.

. 2002 Nov 15;35(10):1273-5.

doi: 10.1086/343746.

Authors

Brian A Potoski, Jack Brown

PMID: 12410490
DOI: 10.1086/343746

No abstract available

PubMed Disclaimer

Comment in

Safety of voriconazole and dose individualization.
Lutsar I, Hodges MR, Tomaszewski K, Troke PF, Wood ND. Lutsar I, et al. Clin Infect Dis. 2003 Apr 15;36(8):1087-8. doi: 10.1086/374248. Clin Infect Dis. 2003. PMID: 12684928 No abstract available.
Lack of cross-hepatotoxicity between fluconazole and voriconazole.
Spellberg B, Rieg G, Bayer A, Edwards JE Jr. Spellberg B, et al. Clin Infect Dis. 2003 Apr 15;36(8):1091-3. doi: 10.1086/374255. Clin Infect Dis. 2003. PMID: 12684933 No abstract available.

Comment on

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
Denning DW, Ribaud P, Milpied N, Caillot D, Herbrecht R, Thiel E, Haas A, Ruhnke M, Lode H. Denning DW, et al. Clin Infect Dis. 2002 Mar 1;34(5):563-71. doi: 10.1086/324620. Epub 2002 Jan 22. Clin Infect Dis. 2002. PMID: 11807679 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems